EMA: First clinical biomarker qualification released for public consultation

17.02.2011

The European Medicines Agency has released the first qualification opinion for a clinical biomarker for public consultation. The biomarker is intended to identify patients who can be recruited for clinical trials of treatments for pre-dementia Alzheimer\'s disease.